Skip to content

Adjuvant X-ray & 5-Fluorouracil (5-FU) Infusion Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN32414363
Enrollment
4000
Registered
2001-02-28
Start date
1989-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer Colorectal cancer

Interventions

There are four treatment groups with all groups receiving surgery. 1. The first group receives peri-operative radiotherapy 2. The second group receives portal-vein infusion 3. The third group receive

Sponsors

Medical Research Council (MRC) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Suspected malignant carcinoma of rectum or colon 2. The patient must be fit for external radiation therapy (XRT) or 5-FU if allocated 3. The surgeon is uncertain whether adjuvant treatment is indicated

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Survival time; Local recurrence; Metastases

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 4, 2026